Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-concentration Atropine for Myopia Progression
NCT06708156Phase 3Recruiting
- Sponsor
- Anhui Oupushifang Pharmaceutical Technology Co., Ltd.
- Start
- Jun 2024
- Primary completion
- Dec 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Myopine in myopia, sponsored by Anhui Oupushifang Pharmaceutical Technology Co., Ltd.. Started Jun 2024; status: recruiting.
02
Drugs
Myopine
03
Conditions
myopia
Beyond the preview
Go deeper on NCT06708156.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06708156.